PURPLE is helping researchers develop new approaches to treat patients with pancreatic cancer. Better research. Better care. Better outcomes.

The PURPLE Translational Registry supports a number of important pancreatic cancer initiatives including clinical trials, laboratory-based research, and screening studies that focus on optimising treatments based on markers that can be detected in a patient's blood or cancer.

Have an idea for a research study? Read about the types of studies the PURPLE Platform supports and submit an expression of interest.